Mind Pharmaceutical LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCharlottesville, VA
SAM.gov UEIP6JVM88C5P65
Mind Pharmaceuticals is a clinical-stage pharmaceutical company developing drugs for treatment-resistant depression and headache disorders. The company's lead candidate, MIND001, is an intravenous formulation of N,N-Dimethyltryptamine (DMT), a naturally occurring psychedelic that acts as an agonist of 5HT2A receptors. The company has completed an exploratory clinical trial with 10 patients with treatment-resistant depression and has another trial underway with 60 patients.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Mind Pharmaceutical LLC | Charlottesville | VA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.